ESC 365 - Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study.

ESC Premium Access

Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study.

Session: Device-based therapy in hypertension

Topic: Device Treatment and Intervention

Speaker: Professor M. Schlaich (Perth, AU)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Markus Schlaich

Royal Perth Hospital - University of Western Australia, Perth (Australia)

1 follower

4 more presentations in this session

Device-based therapy in hypertension - State of the Art

Speaker: Professor F. Mahfoud (Basel, CH)

Evaluation of later morphologic alterations in renal artery wall and nerves in response to catheter-based renal denervation in sheep: comparison of the single-point and multiple-point RDN catheters

Speaker: Professor M. Taborsky (Olomouc, CZ)

Refractory and resistant hypertension in diabetic patients: different metabolic profile, different response to renal denervation

Speaker: Doctor A. Falkovskaya (Tomsk, RU)

Cancelled presentation - The sympathetic nervous system in hypertension: a rational treatment target?

Access the full session

Device-based therapy in hypertension

Speakers: Professor M. Schlaich, Professor F. Mahfoud, Professor M. Taborsky, Doctor A. Falkovskaya

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources